MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'bupropion'. Sat, 03 Sep 2011 02:17:16 +0100 http://www.medworm.com/index.php?rid=4304879&cid=t_102622_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Ffda-set-to-approve-new-anti-obesity-drug%2F2011.01.02 The FDA has been tough on diet drugs of late. Three years ago it scuttled an attempt to get the European diet drug rimonabant approved for use in the U.S. More recently it rejected, at least temporarily, applications for Qnexa and Lorcaserin. But that trend may have been reversed last week, when an advisory committee set the stage for possible FDA approval of Orexigen’s investigational diet drug, Contrave. By a 13-7 vote, the committee said in essence that the somewhat modest beneficial effects of the drug outweighed its tendency to increase blood pressure. The FDA will make final decision on the matter by the end of January. It is not required to follow the advice of its advisory committees, but as was the case for the three diet drugs mentioned above,  it usually does. (more…... Better Health blogs http://www.medworm.com/rss/comments.php?id=4304879 Sun, 02 Jan 2011 19:00:19 +0100 4304879 http://www.medworm.com/index.php?rid=3942790&cid=t_102622_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fstop-smoking-treatment-dont-stop-it-too-soon%2F2010.09.07 Doctors may want their patients to stick with a smoking cessation regimen even if it’s not initially working, report researchers who found that “delayed quitters” accounted for a third of former smokers who went a year without cigarettes. Quit rates may be significantly increased by just continuing in motivated but initially unsuccessful patients during the first eight weeks of treatment, according to research published online in the journal Addiction. There’s actually two types of successful quitters: Those who quit immediately and those who are “delayed” but eventually successful. (more…) *This blog post was originally published at ACP Internist* (Source: Better Health) Better Health blogs http://www.medworm.com/rss/comments.php?id=3942790 Tue, 07 Sep 2010 18:00:00 +0100 3942790 http://www.medworm.com/index.php?rid=3618087&cid=t_102622_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FeIKSx7mehTc%2F This isn’t surprising. A new survey finds that 78 of those seeking treatment for depression or anxiety were prescribed antidepressants, but roughly half of those taking such a pill report being helped ‘a lot.’ Meanwhile, 91 percent of respondents who stuck with ‘talk therapy, reported this approach made things “a lot” or “somewhat” better, according to Consumer Reports, which conducted the survey. The survey also found that older, often less expensive SSRI antidepressants - selective serotonin reuptake inhibitors such as Lexapro, Celexa, Prozac and Zoloft - work just as well, and with fewer side effects, than newer, more costly SNRIs, including Cymbalta and Effexor (see Consumer Reports cost data here). Last year, doctors prescribed $9.9 billion worth of ant... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3618087 Tue, 01 Jun 2010 15:31:11 +0100 3618087 http://www.medworm.com/index.php?rid=1856391&cid=t_102622_109_f&fid=35671&url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_alcohol_significantly_lowers_the_seizure_threshol.htm Conclusion: These results show that in mice alcohol lowers the seizure threshold for bupropion-induced seizures. Clinical implications are firstly that there may be an increased risk of seizures in patients consuming alcohol, and secondly that formulations that can release bupropion more readily in alcohol may present additional risks to patients. (Text has been reformatted for clarity; ed.) Source + Full text... © 2008 Silverstone et al; licensee BioMed Central Ltd. (Source: Latest entries from www.anxietyinsights.info) Latest entries from www.anxietyinsights.info blogs http://www.medworm.com/rss/comments.php?id=1856391 Tue, 07 Oct 2008 07:23:00 +0100 1856391 http://www.medworm.com/index.php?rid=1393712&cid=t_102622_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2008%2F04%2F23%2Fwhen-a-generic-isnt-equal-to-the-brand-name%2F Walmart has made $4 generics the talk of medicine. But are generic medications always as good as their name-brand counterparts? Not always. The Wall Street Journal yesterday wrote an entry yesterday about how they differ — Inexact Copies: How Generics Differ From Brand Names. The spotlight is shining on generics because of their low cost and increasing reports about how being switched to a generic form of a medication can lead to negative side effects not experienced on the brand-name drug. By law, generics must demonstrate “bioequivalence,” a scientific term meaning that their chemical composition and uptake by the body should be similar (but not necessarily exactly the same). Given how people can react to even slight medication changes, it shouldn’t be surprisin... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=1393712 Wed, 23 Apr 2008 12:55:00 +0100 1393712 http://www.medworm.com/index.php?rid=983324&cid=t_102622_109_f&fid=35671&url=http%3A%2F%2Fwww.anxietyinsights.info%2Ffda_probing_generic_wellbutrin_xl.htm FDA Investigating Generic Antidepressant Wellbutrin XL After Complaints TORONTO (AP) — The U.S. Food and Drug Administration said Thursday it is investigating complaints about a generic version of the antidepressant drug Wellbutrin XL after users reported having headaches, anxiety and other ailments. FDA spokesperson Sandy Walsh told Dow Jones Newswires the agency is also reviewing the scientific formulation of the drug, called Budeprion XL, after a consumer-product testing group published results that showed key differences from the original drug. More... Copyright © 2007 The Associated Press. All rights reserved. (Source: Latest entries from www.anxietyinsights.info) Latest entries from www.anxietyinsights.info blogs http://www.medworm.com/rss/comments.php?id=983324 Sat, 27 Oct 2007 08:38:00 +0100 983324 http://www.medworm.com/index.php?rid=713108&cid=t_102622_109_f&fid=34699&url=http%3A%2F%2Fscienceblogs.com%2Fcorpuscallosum%2Fimages%2Fbupropion.png This is another post in a series detailing the selection of antidepressant medication.  Use the "Antidepressants" link in the "Categories" part of the sidebar to find the other posts in the series. In this post, I am sort of assuming that the reader has read the previous posts, or has an adequate fund of general knowledge on the subject. Bupropion is not a member of a family.  Most antidepressants can be placed in a family of drugs that share similar properties, but there is no other drug like it, as of the time of this writing.  It is sometimes referred to as a norepinephrine-dopamine reuptake inhibitor (NDRI) but in my mind it does not make sense to give it a class name if there is only one member of the class. (It is rumored that an active metabolite, hydroxybupropion, ... The Corpus Callosum blogs http://www.medworm.com/rss/comments.php?id=713108 Tue, 03 Jul 2007 18:41:26 +0100 713108 http://www.medworm.com/index.php?rid=478754&cid=t_102622_87_f&fid=34867&url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F03%2F07%2Fanalyze-this-for-better-blood-sugar-control%2F Filed under: Type 1, Type 2, Childhood, Adult Onset, Lifestyle, Drugs, Research, ProductsRemember that movie with Billy Crystal and Robert De Niro, Analyze This? Well we all don't have super-risky mobster lifestyles to induce depression like Paul Vitti's, but according to a new study of depressed type 2 diabetics -- depression has a negative impact on blood sugar control. Researchers treated 93 patients with type 2 diabetes and depression with the antidepressant bupropion (Wellbutrin). They chose the drug because it is capable of reducing depression and weight simultaneously. The hypothesis behind the treatment was mood enhancement and weight reduction would, in fact, improve blood sugar control. (Always a gold star day in my book!) The results were documented in the March issue of Diabete... The Diabetes Blog blogs http://www.medworm.com/rss/comments.php?id=478754 Wed, 07 Mar 2007 05:00:00 +0100 478754